A NEW IMMUNOMODULATORY COMPOUND FOR THE TREATMENT OF AUTOIMMUNE DISEASES
Autoimmune diseases are debilitating conditions that affect a large and growing portion of the population. There are >80 different autoimmune diseases, affecting ~50 million Americans. These diseases are chronic and can be life-threatening; they are the second highest cause of chronic illness, and the top cause of morbidity in women in the United States.
TPCera is developing a breakthrough new immunomodulatory compound, invented by Prof. Yehuda Shoenfeld and Prof. Miri Blank.
CEO – Dr. Isaac Tal